Request Clinical Starter Kits for Your Patients Today! Request Now

 STUDIES

Healthy and pre-diabetic adults achieve better gut microflora balance with PreticX™ xylooligosaccharides, study shows

Highlights Randomized, double-blind, placebo-controlled pilot study with healthy (n=16) and pre-diabetic (n=13) adults Supplementation consists of 2 g/day xylooligosaccharides (XOS) from PreticX™ for 8 weeks Compared to placebo, PreticX™ XOS has a...
on February 25, 2020

Healthy adults achieve better gut microflora balance with PreticX™ xylooligosaccharides, study shows

Highlights Randomized, double-blind, placebo-controlled trial with 32 healthy men and women Supplementation consists of 1-2 g/day xylooligosaccharides from PreticX™ for 8 weeks Compared to placebo, supplementing with PreticX™ significantly increases Bifidobacteria...
on February 25, 2020

Grape seed extract significantly reduces blood pressure, meta-analysis shows

Highlights Meta-analysis of 16 randomized, placebo-controlled clinical trials comprising 810 subjects Grape seed extract (GSE) dosages from 100 to 2,000 mg/day for 2 to 12 weeks GSE significantly reduces blood pressure compared to...
on February 25, 2020

Grape seed extract reduces blood levels of glucose, lipids and inflammatory C-reactive protein, meta-analysis shows

Highlights Meta-analysis of 15 RCTs with 825 participants (healthy and unhealthy) Grape seed extract reduces blood levels of glucose, lipids and inflammatory CRP Dosages range from 100 mg/day to 2 g/day...
on February 25, 2020

Extended-release nicotinic acid significantly lowers lipoprotein(a) in patients with heart disease or diabetes, meta-analysis shows

Highlights Meta-analysis includes 14 randomized, placebo-controlled, clinical trials with over 9,000 participants Study dosages of extended-release nicotinic acid range from 1,000 to 3,000 mg/day; study durations, from 8 to 26 weeks A...
on February 25, 2020
"